Log In
BCIQ
Print this Print this
 

Armira

  Manage Alerts
Collapse Summary General Information
Company Prolias Technologies Inc.
DescriptionNon-invasive blood based molecular diagnostic test to diagnose kidney rejection
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationTransplant, Diagnostic
Indication DetailsTest to diagnose kidney transplant rejection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today